Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Blue

Recent news which mentions Blue

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Bluebird (BLUE) Stock Soars 25% Following 2 FDA Recommendations
Tickers BLUE
Tags Today's Market NASDAQ:BLUE Market News
From InvestorPlace
Mid-Morning Market Update: Markets Open Lower; Dow Drops 600 Points
Tickers APLD APPH BLUE DAWN
Tags Small Cap ELSE Benzinga
From Benzinga
FDA Advisory Committee Backs Bluebird Bio's Blood Disorder Gene Therapy
Tickers BLUE
Tags Health Care Briefs Movers
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Tickers ABVC ACXP ALRN BLUE
Tags ZSAN ACXP BZI/TFM
From Benzinga
Bluebird Bio stock rises 62%, FDA committee supports treatments
Tickers BLUE
Tags BLUE
From MarketWatch
An FDA Approval Could Send This Stock Soaring by August
Tickers BLUE
Tags Recent Press Releases Market News BLUE
From Motley Fool
Bluebird Bio Secures FDA Advisory Committee's Endorsement For Neurodegenerative Disease Drug
Tickers BLUE
Tags Benzinga FDA General
From Benzinga
FDA Sounds Positive On Bluebird's One Gene Therapy But Doubts Another
Tickers BLUE
Tags Penny Stocks Movers Market News
From Benzinga
6 Biotech Stocks to Buy Now Ahead of These June Catalysts
Tickers ACAD AXSM BLUE BMY
Tags BLUE Market News ACAD
From InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
Tickers ACOR ADN AERI AFIB
Tags CDAK 52/Week Lows IONM
From Benzinga
TC BioPharm Reports Racing Toward What Could Be A Major Cancer Immunotherapy Breakthrough
Tickers BLUE TCBP
Tags Penny Stocks TCBP BLUE
From Benzinga
Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates
Tickers ACAD ACER AMLX BLUE
Tags ACER REGN PHAT
From Benzinga
7 Cheap Biotech Stocks to Buy Now
Tickers AMGN BCRX BLUE BNGO
Tags VSTM SELB Stocks to Buy
From InvestorPlace
2 High-Risk, High-Reward Stocks for Contrarian Investors
Tickers BLUE PRVB
Tags PRVB Market News BLUE
From Motley Fool
These 5-Stock Samplers Have Gotten Whacked. And That's OK
Tickers AAPL ABNB AMGN AMZN
Tags AVAV ATVI PTON
From Motley Fool
Why This Analyst Has 'Little Conviction' On CRISPR's Upcoming Trial Data
Tickers ALLO BLUE CRSP VRTX
Tags Health Care VRTX Briefs
From Benzinga
Analyst Ratings for bluebird bio
Tickers BLUE
Tags Benzinga BZI/AAR Analyst Ratings
From Benzinga
92 Biggest Movers From Friday
Tickers ACOR ACRX AERI AMLX
Tags SWVL VRPX BILL
From Benzinga
55 Stocks Moving In Friday's Mid-Day Session
Tickers AOSL ATGE AVDX BBIG
Tags Penny Stocks GANX BBIG
From Benzinga
Where Will Bluebird Bio Be in 1 Year?
Tickers BLUE
Tags Recent Press Releases BLUE Market News
From Motley Fool
Is Bluebird Bio a Buy?
Tickers BLUE
Tags Recent Press Releases BLUE Market News
From Motley Fool
Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks
Tickers BIIB BLUE GILD IBB
Tags BIIB IBB MRK
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
Tickers ABMD AMP APTV ARRY
Tags SAVE LNDC NWE
From Benzinga
Expert Ratings For bluebird bio
Tickers BLUE
Tags Analyst Ratings Market News BLUE
From Benzinga
10 Biggest Price Target Changes For Wednesday
Tickers AMP BLUE C CANO
Tags Penny Stocks Pre/Market Outlook Market News
From Benzinga
Bluebird Bio Joins Layoff Band Wagon As Gene Therapy Biotech Cuts Staff To Reduce Costs
Tickers BLUE
Tags General News Biotech
From Benzinga
FDA Recommends At Least 15 years Of Follow-Up For Genome Editing Product Trials
Tickers BLUE NTLA
Tags General NTLA Biotech
From Benzinga
Why Bluebird Bio Stock Is Sinking This Week
Tickers BLUE
Tags Recent Press Releases Market News BLUE
From Motley Fool
bluebird bio's Return On Capital Employed Insights
Tickers BLUE
Tags BLUE Market News BZI/ROCE
From Benzinga
76 Biggest Movers From Yesterday
Tickers ADTH ANTE APPH ARMP
Tags Top Gainers Small Cap NRSN
From Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.